deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT00668785

Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)

Sponsor: Genentech, Inc.

Conditions Macular Edema Proliferative Diabetic Retinopathy
Interventions ranibizumab
Updated 11 times since 2017 Last updated: Feb 13, 2019 Started: Mar 31, 2007 Primary completion: Jun 30, 2010 Completion: Mar 31, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study was terminated due to low enrollment

Other terminated trials from Genentech, Inc.

More terminations from Genentech, Inc.

Other Macular Edema trials with similar outcome

Browse all Macular Edema trials

A PHASE2 clinical study on Macular Edema and Proliferative Diabetic Retinopathy, this trial is terminated or withdrawn. The trial is conducted by Genentech, Inc. and has accumulated 11 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshotTerminated~Oct 2018 – ~Apr 2019 · 6 months · monthly snapshotTerminated~Apr 2019 – ~Jan 2021 · 21 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE2

  5. Dec 2021 — Dec 2022 [monthly]

    Terminated PHASE2

▶ Show 6 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE2

  2. Apr 2019 — Jan 2021 [monthly]

    Terminated PHASE2

  3. Oct 2018 — Apr 2019 [monthly]

    Terminated PHASE2

  4. Jun 2018 — Oct 2018 [monthly]

    Terminated PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE2

  6. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE2

    First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Genentech, Inc.
  • Jumper, J. Michael, M.D.
Data source: Jumper, J. Michael, M.D.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations